Compare MYD & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYD | TOI |
|---|---|---|
| Founded | 1991 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.7M | 444.1M |
| IPO Year | N/A | N/A |
| Metric | MYD | TOI |
|---|---|---|
| Price | $10.49 | $3.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 253.1K | ★ 2.9M |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 4.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $461,039,000.00 |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | N/A | $23.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | $8.76 | $0.17 |
| 52 Week High | $11.30 | $4.88 |
| Indicator | MYD | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 52.50 |
| Support Level | $10.45 | $2.99 |
| Resistance Level | $10.59 | $3.32 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 66.67 | 96.92 |
Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes. The fund invests a majority of its assets in municipal bonds exempt from U.S. federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax). These bonds are predominantly long-term (with a maturity of more than ten years at the time of investment), and rated as investment grade, or deemed to be of comparable quality by the investment adviser at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.